Patent ID: 9315459
Filing Date: 2016-04-19
CPC Classification: A61P,C07B,C07C,C07D

Claim Text:
1. Compound I, which is 4-[2-(4-methylphenylsulfanyl)phenyl]-piperidine, and pharmaceutically acceptable salts thereof, in a crystalline form, selected from the group consisting of: a malonic acid addition salt (1:1) characterized by peaks in an XRPD at 10.77°±0.1°, 16.70°±0.1°, 19.93°±0.1° and 24.01°±0.1° 2θ; a malonic acid addition salt (1:1) characterized by peaks in an XRPD at 6.08°±0.1°, 10.11°±0.1°, 18.25°±0.1° and 20.26°±0.1° 2θ; a L-aspartic acid addition salt (1:1) characterized by peaks in an XRPD at 11.05°±0.1°, 20.1°±0.1°, 20.60°±0.1° and 25.00°±0.1° 2θ; and a L-aspartic acid addition salt hydrate (1:1) characterized by peaks in an XRPD at 7.80°±0.1°, 13.80°±0.1°, 14.10°±0.1° and 19.63°±0.1° 2θ.